已更新
RAD - DAILY CHART
Hi, today we are going to talk about Rite Aid and its current landscape.
Rite Aid is poised to receive increasing attention from the market as relevant events are taking place. The American drugstore chain issued better than expected EPS, and sales results for its third-quarter report also raised its fiscal-year EPS guidance above estimates. Positive news that can be attributed to the company's efforts to deploy its new strategy, which includes investment into its pharmacy benefit manager.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
Rite Aid is poised to receive increasing attention from the market as relevant events are taking place. The American drugstore chain issued better than expected EPS, and sales results for its third-quarter report also raised its fiscal-year EPS guidance above estimates. Positive news that can be attributed to the company's efforts to deploy its new strategy, which includes investment into its pharmacy benefit manager.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
注释
target 1 and 2 reached!
Igor Silva · análise técnica e sistemas quantitativos
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
Igor Silva · análise técnica e sistemas quantitativos
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。